Elinzanetant (Lynkuet): Side Effects, Cost, and More

Breast Cancer.org·Jan 8

This story is reported by Breast Cancer.org. Read what other outlets are saying below, then open the original report for full details.

Full coverage

1

Bayer’s Lynkuet® (elinzanetant), the First and Only Neurokinin 1 and Neurokinin 3 Receptor Antagonist, Receives FDA Approval for Moderate to Severe Hot Flashes Due to Menopause

Business Wire·Oct 24

2

FDA approves a new drug for hot flashes. Here’s what to know about it.

The Washington Post·Oct 29

3

New menopause drug without hormones approved by FDA. A doctor shares what to know.

CBS News·Oct 27

4

New Menopause Drug Lynkuet Could Ease Hot Flashes and Night Sweats

Verywell Health·Nov 5

5

FDA Approves New Menopause Drug to Treat Hot Flashes and Night Sweats - The New York Times

The New York Times·Oct 24

6

5 Nonhormonal Medications for Menopause Symptoms

GoodRx·Dec 12

7

Another FDA mini-pause for Bayer's menopause candidate?

Fierce Pharma·Jul 28